Antiatherosclerotic effect of Ang- (1-7) non-peptide mimetic (AVE 0991) is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.

Article English OPEN
Skiba, D.S. ; Nosalski, R. ; Mikolajczyk, T.P. ; Siedlinski, M. ; Rios, F.J. ; Montezano, A.C. ; Jawien, J. ; Olszanecki, R. ; Korbut, R. ; Czesnikiewicz-Guzik, M. ; Touyz, R.M. ; Guzik, T.J. (2017)
  • Publisher: Wiley
  • Journal: British Journal of Pharmacology (issn: 0007-1188, vol: 174, pp: 4,055-4,069)
  • Related identifiers: pmc: PMC5659999, doi: 10.1111/bph.13685
  • Subject: Research Paper | Themed Section: Research Papers

Background and Purpose: \ud \ud Inflammation plays a key role in atherosclerosis. The protective role of angiotensin 1–7 (Ang-(1–7)) in vascular pathologies suggested the therapeutic use of low MW, non-peptide Ang-(1–7) mimetics, such as AVE0991. The mechanisms underlying the vaso-protective effects of AVE0991, a Mas receptor agonist, remain to be explored.\ud Experimental Approach: \ud \ud We investigated the effects of AVE0991 on the spontaneous atherosclerosis in apolipoprotein E (ApoE)−/− mice, in the context of vascular inflammation and plaque stability.\ud Key Results: \ud \ud AVE0991 has significant anti-atherosclerotic properties in ApoE−/− mice and increases plaque stability, by reducing plaque macrophage content, without effects on collagen. Using the descending aorta of chow-fed ApoE−/− mice, before significant atherosclerotic plaque develops, we gained insight to early events in atherosclerosis. Interestingly, perivascular adipose tissue (PVAT) and adventitial infiltration with macrophages and T-cells precedes atherosclerotic plaque or the impairment of endothelium-dependent NO bioavailability (a measure of endothelial function). AVE0991 inhibited perivascular inflammation, by reducing chemokine expression in PVAT and through direct actions on monocytes/macrophages inhibiting their activation, characterized by production of IL-1β, TNF-α, CCL2 and CXCL10, and differentiation to M1 phenotype. Pretreatment with AVE0991 inhibited migration of THP-1 monocytes towards supernatants of activated adipocytes (SW872). Mas receptors were expressed in PVAT and in THP-1 cells in vitro, and the anti-inflammatory effects of AVE0991 were partly Mas dependent.\ud Conclusions and Implications: \ud \ud The selective Mas receptor agonist AVE0991 exhibited anti-atherosclerotic and anti-inflammatory actions, affecting monocyte/macrophage differentiation and recruitment to the perivascular space during early stages of atherosclerosis in ApoE−/− mice.\ud Linked Articles: \ud \ud This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc
  • References (41)
    41 references, page 1 of 5

    Ait-Oufella H, Taleb S, Mallat Z, Tedgui A (2011). Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 969-979.

    Ketelhuth DF, Hansson GK (2016). Adaptive response of T and B cells in atherosclerosis. Circ Res 118: 668-678.

    Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010).

    Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.

    (2014). DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest 124: 4642-4656.

    Klein S, Herath CB, Schierwagen R, Grace J, Haltenhof T, Uschner FE et al. (2015). Hemodynamic effects of the non-peptidic angiotensin-(1-7) agonist AVE0991 in liver cirrhosis. PLoS One 10: e0138732.

    Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA et al. (2001). Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288.

    (2015). Effect of a selective Mas Receptor agonist in cerebral ischemia in vitro and in vivo. PLoS One 10: e0142087.

    Libby P, Ridker PM, Hansson GK (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317-325.

    Ma Y, Huang H, Jiang J, Wu L, Lin C, Tang A et al. (2016). AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress.

  • Similar Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark